<table class="infobox infobox-protein"> <tr><th class="infobox-header" colspan="2">MAPK3 Protein (ERK1)</th></tr> <tr><td class="label">Protein Name</td><td>Mitogen-Activated Protein Kinase 3</td></tr> <tr><td class="label">Gene</td><td><a href="/genes/mapk3">MAPK3</a></td></tr> <tr><td class="label">UniProt</td><td><a href="https://www.uniprot.org/uniprot/P27361" target="_blank">P27361</a></td></tr> <tr><td class="label">Molecular Weight</td><td>~43 kDa</td></tr> <tr><td class="label">Subcellular Localization</td><td>Cytoplasm, Nucleus</td></tr> <tr><td class="label">Protein Family</td><td>MAP kinase family, CMGC group</td></tr> <tr><td class="label">Aliases</td><td>ERK1, p44 MAP Kinase, p44erk</td></tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">276 edges</a></td> </tr> </table>
MAPK3 Protein (ERK1)
Pathway Diagram ...
<table class="infobox infobox-protein"> <tr><th class="infobox-header" colspan="2">MAPK3 Protein (ERK1)</th></tr> <tr><td class="label">Protein Name</td><td>Mitogen-Activated Protein Kinase 3</td></tr> <tr><td class="label">Gene</td><td><a href="/genes/mapk3">MAPK3</a></td></tr> <tr><td class="label">UniProt</td><td><a href="https://www.uniprot.org/uniprot/P27361" target="_blank">P27361</a></td></tr> <tr><td class="label">Molecular Weight</td><td>~43 kDa</td></tr> <tr><td class="label">Subcellular Localization</td><td>Cytoplasm, Nucleus</td></tr> <tr><td class="label">Protein Family</td><td>MAP kinase family, CMGC group</td></tr> <tr><td class="label">Aliases</td><td>ERK1, p44 MAP Kinase, p44erk</td></tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">276 edges</a></td> </tr> </table>
MAPK3 Protein (ERK1)
Pathway Diagram
Mermaid diagram (expand to render)
Introduction MAPK3 , also known as ERK1 (Extracellular Signal-Regulated Kinase 1), is a serine/threonine protein kinase encoded by the [MAPK3](/genes/mapk3) gene. It belongs to the MAP kinase family and plays critical roles in cellular signal transduction, gene expression regulation, cell proliferation, and neuronal function. The MAPK/ERK pathway is one of the most important signaling cascades in the nervous system, regulating synaptic plasticity, memory formation, and neuronal survival. Dysregulation of MAPK3 signaling is implicated in the pathogenesis of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative disorders [1].
Structure MAPK3 (ERK1) has the typical MAP kinase domain organization:
Kinase Domain
N-terminal kinase domain (~300 residues
Contains the characteristic DF/LYXXXXF motif
ATP-binding site in the cleft
Activation Loop
Contains the TEY (Thr-Glu-Tyr) dual phosphorylation motif
Thr202 and Tyr204 are phosphorylated for activation
Phosphorylation by MEK1/2 activates the kinase
C-terminal Region
Common docking (CD) domain for substrate selection
FERP (FXXP/FR) motif for interactions
Structural Features
Overall 83% identity to ERK2
Longer N-terminal region than ERK2
Forms dimers upon activation
Normal Function
Signal Transduction MAPK3/ERK1 is a central node in cellular signaling:
MAP kinase cascade : Activated by Ras-Raf-MEK-ERK
Growth factor signaling : Responds to BDNF, NGF, EGF
Cell surface to nucleus : Transduces extracellular signals
Neuronal Functions In [neurons](/entities/neurons), MAPK3 has critical roles:
Synaptic plasticity :
[NMDA receptor](/entities/nmda-receptor)-dependent signaling
[Long-term potentiation](/mechanisms/long-term-potentiation) (LTP)
Memory consolidation
Neuronal development :
Neuronal differentiation
Axonal guidance
Dendrite morphogenesis
Neuroprotection :
Responses to neurotrophic factors
Anti-apoptotic signaling
Stress adaptation
Gene Expression Regulation ERK1 phosphorylates transcription factors:
ELK-1, c-Fos, c-Myc
CREB
Stat proteins
Role in Neurodegeneration
Alzheimer's Disease MAPK3 is implicated in AD pathogenesis:
[Tau](/proteins/tau) pathology :
Co-localizes with neurofibrillary tangles [2]
Can phosphorylate tau at multiple sites
May contribute to tau hyperphosphorylation
Amyloid-β signaling :
[Aβ](/proteins/amyloid-beta) activates MAPK3/ERK1 pathway
May mediate Aβ-induced toxicity
Complex role in Aβ responses
Synaptic dysfunction :
Altered ERK signaling in AD brains
Contributes to synaptic plasticity deficits
Memory impairment mechanisms
Parkinson's Disease MAPK3 involvement in PD:
Dopaminergic neuron survival :
Neurotrophin signaling in substantia nigra
Responses to stress
Altered in PD models
[α-Synuclein](/proteins/alpha-synuclein) pathology :
ERK activation in Lewy bodies
May respond to α-synuclein aggregation
Complex role in neurodegeneration
Neuroinflammation :
Activated in [microglia](/cell-types/microglia-neuroinflammation)
May contribute to neuroinflammation
Stroke and Brain Injury
Activated by ischemia
Both protective and damaging roles
Potential therapeutic target
Other Conditions
Depression : ERK signaling in mood disorders
Addiction : Reward pathway signaling
Multiple sclerosis : Demyelination signaling
Therapeutic Implications MAPK3 is a therapeutic target:
Kinase Inhibitors
MEK inhibitors (upstream blockers)
Direct ERK inhibitors (in development)
Neurotrophin-based Approaches
BDNF mimetics
TrkB agonists
Modulation Strategies
Targeting downstream effectors
Substrate-specific inhibitors
Research Findings Key findings:
ERK1/2 have overlapping but distinct functions
Genetic deletion of ERK1 enhances memory
ERK2 more critical for development
See Also
[MAPK3 Gene](/genes/mapk3)
[MAPK1 Protein](/proteins/mapk1-protein)
[MAP Kinase Signaling](/mechanisms/mapk-signaling)
[Alzheimer's Disease Pathogenesis](/mechanisms/alzheimers-disease-pathogenesis)
[Parkinson's Disease Pathogenesis](/mechanisms/parkinsons-disease-pathogenesis)
[Synaptic Plasticity](/mechanisms/synaptic-plasticity)
References
[Unknown, Subramaniam & Unsicker, ERK signaling in neurodegeneration (2010) (2010)](https://doi.org/10.1111/j.1471-4159.2010.06922.x)
[Gartner et al., ERK and tau in AD (1999) (1999)](https://doi.org/10.1016/S0301-0082(99)
[Unknown, Roskoski, ERK1/2 inhibitors (2012) (2012)](https://doi.org/10.1016/j.pharmthera.2012.09.007)
Pathway Diagram The following diagram shows the key molecular relationships involving MAPK3 Protein (ERK1) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description